Cytokinetics, Incorporated (CYTK) — Stock Score Summary

Cytokinetics, Incorporated (CYTK) has a MoatMap StockRank of 42/100 based on Quality (22/100), Value (46/100), and Momentum (62/100) factor scores. The current signal is HOLD. This clinical-stage biopharmaceutical company is highly binary and speculative, failing our Terry Smith quality compounder lens.

Cytokinetics, Incorporated is a biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors for the treatment of debilitating diseases. Its competitive moat lies in a proprietary drug discovery platform targeting muscle function, with a lead candidate currently in advanced clinical trials for heart failure. Cytokinetics is a clinical-stage biotech firm specializing in muscle biology, aiming to address significant unmet medical needs in cardiovascular and neuromuscular diseases.

Key Financial Metrics

Price$68.45
Market Cap$10.4B
P/E (Forward)-15.21
Price/Book-10.87
Return on Invested Capital-55.7%
Gross Margin-290.7%
Operating Margin-948.7%
Revenue Growth1125.8%
Free Cash Flow$-381M

Cytokinetics, Incorporated operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Cytokinetics, Incorporated’s (CYTK) StockRank?
MoatMap’s StockRank for Cytokinetics, Incorporated (CYTK) is 42/100, with a Hold signal. It is a composite of Quality (22), Value (46), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Cytokinetics, Incorporated have an economic moat?
Cytokinetics, Incorporated (CYTK) has a Quality factor score of 22/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cytokinetics, Incorporated a buy, hold, or sell?
MoatMap’s current signal for Cytokinetics, Incorporated (CYTK) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cytokinetics, Incorporated in?
Cytokinetics, Incorporated (CYTK) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksCYTK deep dive reportAI ChampionsHow we score stocksSense-check another stock